ChemicalBook > Produktkatalog >Aktive pharmazeutische Wirkstoffe (APIs) >Hormone und das endokrine System >Arzneimittel gegen erektile Dysfunktion >Darifenacin

Darifenacin

133099-04-4

CAS-Nr.: 133099-04-4

Englisch Name:: Darifenacin

Synonyma:: CS-773;UK88525;UK-88525;UK 88525;DARIFENACIN;Darifenacin, >=98%;Darifenacin USP/EP/BP;Tolafentrine Impurity 16;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphe

CBNumber:: CB1506695

Summenformel:: C28H30N2O2

Molgewicht:: 426.55

MOL-Datei:: 133099-04-4.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 126

Darifenacin Eigenschaften

alpha: 25D -20.6° (c = 1.0 in methylene chloride)

Siedepunkt:: 614.3±55.0 °C(Predicted)

Dichte: 1.192±0.06 g/cm3(Predicted)

storage temp.: 2-8°C

Löslichkeit: Soluble in DMSO

Aggregatzustand: Powder

pka: pKa (25°): 9.2

Sicherheit

Darifenacin Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Treatment for an overactive bladder.

Definition

ChEBI: 2-[(3S)-1-Ethylpyrrolidin-3-yl]-2,2-diphenylacetamide in which one of the hydrogens at the 2-position of the ethyl group is substituted by a 2,3-dihydro-1-benzofuran-5-yl group. It is a selective antagonist for the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, and is used as the hydrobromide salt in the management of urinary incontinence.

Darifenacin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

1189753-52-3 2-Oxodarifenacin 5-(2-Bromoethyl)-2,3-dihydrobenzofuran Darifenacin hydrobromide 3-(S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine 5-CHLOROMETHYL-2,3-DIHYDROBENZOFURAN (S)-alpha,alpha-Diphenyl-3-pyrrolidineacetamide Darifenacin Oxidized IMpurity 5-ACETYL-2,3-DIHYDROBENZO(B)FURAN 5-Chloroacetyl-2,3-dihydrobenzofuran 2-BROMO-1-(2,3-DIHYDRO-1-BENZOFURAN-5-YL)ETHANONE 5-(2-chloroethyl)-2,3-dihydrobenzofuran 2,3-Dihydrobenzofuran

Downstream Produkte

Darifenacin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 126)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
career henan chemical co	+86-0371-86658258	sales@coreychem.com	China	29914	58
Hubei xin bonus chemical co. LTD	86-13657291602	linda@hubeijusheng.com	CHINA	22968	58
Chongqing Chemdad Co., Ltd	+86-023-61398051 +8613650506873	sales@chemdad.com	China	39916	58
Alchem Pharmtech,Inc.	8485655694	sales@alchempharmtech.com	United States	63711	58
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	49390	58
Qiuxian Baitai New Material Co., LTD	+8618330912755	sale2@hbyalin.com	China	1677	58
ANHUI WITOP BIOTECH CO., LTD	+8615255079626	eric@witopchemical.com	China	23556	58
Xi'an MC Biotech, Co., Ltd.	029-89275612 +8618991951683	mcbio_sales@163.com	China	2255	58
Shaanxi Dideu Medichem Co. Ltd	+86-029-89586680 +86-18192503167	1026@dideu.com	China	9320	58
Shijiazhuang Gantuo Biotechnology Co., Ltd	+8613373514458	gantuo02@cngantuo.com	China	218	58

133099-04-4()Verwandte Suche:

tadalafi ISOXADIFEN-ETHYL Paracetamol Phenylvalerat Ethanol Piracetam Acetamid Trinexapac-ethyl Ethylacetat Ethyl-4-hydroxybenzoat Thioacetamid Phenylsalicylat N,N-Dimethylacetamid 2-Cyanacetamid Solifenacin Diphenylether PHENYL RESIN Phenylessigsure

2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetaMide
UK 88525
UK88525
UK-88525
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip
Darifenacin, >=98%
DARIFENACIN
2-[1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-di(phenyl)acetamide
(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dipheny
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphe
CS-773
3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, (3S)-
Darifenacin USP/EP/BP
(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α-α-diphenyl-3-pyrrolidineacetamide Hydrobromide
Tolafentrine Impurity 16
133099-04-4
Pharmaceutical material and intermeidates
API